Latency of Klebsiella species and Escherichia coli strains that harbor a conjugative IncA/C type plasmid carrying both rmtB and bla_<CTX-M-14> by Yamane Kunikazu et al.
87Kawasaki Medical Journal 39（3）：87－94，2013
Corresponding author
Kunikazu Yamane
Department of Public Health, Kawasaki Medical School, 
577 Matsushima, Kurashiki, 701-0192, Japan
Phone : 81 86 462 1111
Fax : 81 86 462 1199
E-mail : kkz.yamane@med.kawasaki-m.ac.jp
Latency of Klebsiella species and Escherichia coli strains that harbor a
conjugative IncA/C type plasmid carrying both rmtB and blaCTX-M-14
Kunikazu YAMANE１，２）＊，Jun-ichi WACHINO２，３），Satowa SUZUKI２），
Yoshichika ARAKAWA２，３）
1) Department of Public Health, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan
2) Department of Bacteriology II, National Institute of Infectious Diseases, Musashi-Murayama, Tokyo, 208-0011, Japan
3) Department of Bacteriology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan
ABSTRACT  Six high-level aminoglycoside and third generated cephalosporin of cefotaxime 
resistance Klebsiella pneumoniae , Klebsiella oxytoca , and Escherichia coli  isolated from clinical 
specimens in the same Japanese hospital since 2001.  These 6 strains were resistant to all 
4,6-disubstituted deoxystreptamine including albekacin.  The results of multiplex PCR for 16S 
rRNA methylase and bla TEM, bla SHV, bla CTX-M specific PCR reaction show that these strains harbor 
16S rRNA methylase of rmtB  and β-lactamase resistance gene of bla CTX-M-9 group in the same 
large plasmid.  Sequence analysis of bla CTX-M-9 group PCR products shows this β-lactamase 
is bla CTX-M-14.  rmtB -harbored plasmids are classified the IncA/C by PCR and restriction pattern 
by EcoRI show only one or two band differences.  Moreover, southern hybridization of EcoRI 
digested rmtB  harbored plasmid by rmtB  probe show the same hybridization pattern of 4.8 kbp 
bands.  PFGE fingerprinting analysis of four K. pneumoniae  revealed two fingerprinting patterns. 
These facts suggested that rmtB -positive starains not only spread horizontal transfer of rmtB -
harbored plasmid but also clonal spread of the same strain.
 (Accepted on April 5, 2013)
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INTRODUCTION
   Among antimicrobial agents, aminoglycosides are 
among the efficacious groups of antibiotics against 
pathogenic gram-negative bacteria which usually 
cause life-threatening infections.  Aminoglycosides 
block the peptide bind-forming translocation process 
through binding to the A-site of the 16S rRNA that 
constitutes bacterial 30S ribosome１）.  The most 
frequently encountered resistance mechanism 
against  aminoglycosides  among pathogenic 
bacteria is enzymatic modifications of the -OH or 
-NH2 groups of these agents.  Three modification 
enzymes such as aminoglycoside acetyltransferases 
(AAC), aminoglycoside nucleotidyltransferase/
a d e n y l y l t r a n s f e r a s e s  ( A N T / A A D ) ,  a n d 
aminoglycoside phosphotransferases (APH)２） have 
been identified in various bacterial species.  However, 
these enzymes usually have relatively narrow 
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substrate specificities, and almost all of them hardly 
inactivate multiple aminoglycosides at the same time.
   Mutations at the A-site of 16S rRNA also provide 
a type of resistance to aminoglycosides for various 
bacterial species, but this kind of mutation usually 
has adverse effects on bacterial growth through 
reduction of protein synthesis.  Thus, mutations at 
16S rRNA usually become problematic, especially 
in slow-growing bacteria such as Mycobacterium 
spp.３，４）.  The third molecular mechanism for 
aminoglycoside-resistance is alteration in bacterial 
membrane including active efflux pump systems 
such as MexXY-OprM found in Pseudomonas 
aeruginosa５，６）.  The fourth aminoglycoside-
resistance mechanism is the methylation of bacterial 
16S rRNA, a main target of aminoglycosides. 
Indeed, the 16S rRNA protection by methylation 
gives a very high level of resistance against intrinsic 
aminoglycosides, but this resistance mechanism has 
exclusively been found only among aminoglycoside-
producing bacteria７）, and no such kind of 16S rRNA 
protection had been identified in clinically isolated 
pathogenic bacteria before 2003.  Since 2003, 
seven plasmid-mediated 16S rRNA methylase such 
as RmtA８）, RmtB９）, RmtC10）, RmtD11）, RmtE12）, 
RmtF13）, RmtG (JX486113), ArmA14）, and NpmA15）
have identified Enterobacteriaceae, Pseudomonas 
aeruginosa, and Acinetobacter baumannii.  Our 
study, it was found that various gram-negative 
bacterial species harboring some of these 16S 
rRNA methylases have already been proliferating in 
separate medical facilities in Japan16，17）.  
   From 2001 to 2003, six strains including four 
Klebsiella pneumoniae, one Klebsiella oxytoca, 
and one Escherichia coli that possessed a very high 
level of resistance against various amimoglycosides, 
as well as cefotaxime, were isolated in a Japanese 
hospital.  In the present study, the genetic relations 
among six bacterial strains and their plasmids were 
elucidated.
MATERIALS AND METHODS
Bacterial strains
   From 2001 to 2003, six strains highly resistant 
to both amikacin and gentamicin were isolated 
clinically in a hospital in Japan.  These were four 
K. pneumoniae strains MRY05-304, MRY05-305, 
MRY05-306, and MRY05-307, one K. oxytoca 
MRY05-308, and one E. coli MRY05-309 (Table1). 
Bacterial strains were grown in Luria-Bertani 
(LB) broth or LB agar plates (Becton Dickinson 
Diagnostic Systems, Sparks, Md.) supplemented 
with appropriate antimicrobial agents.
Antimicrobial agents susceptibility test
   MIC of each antimicrobial agent was measured 
by the agar dilution method in accordance with the 
protocol recommended by the CLSI in document 
Table 1.  Bacterial strains used in this study
Bacterial species and strain Characteristics Source or reference
K. pneumoniae strains
      MRY05-304, MRY05-305, 
      MRY05-306, and MRY05-307a
K. oxytoca MRY05-308a
E. coli MRY05-309a
E. coli CSH2
E. coli DH10B
Clinical isolates; strains resistant to amikacin, gentamicin, and cefotaxime isolated in Yamanashi, Japan
Clinical isolate; a strain resistant to amikacin, gentamicin, and cefotaxime isolated in Yamanashi, Japan
Clinical isolate; a strain resistant to amikacin, gentamicin, and cefotaxime isolated in Yamanashi, Japan
metB F– nalidixic acidr rifampinr
F–  mcrA Δ(mrr– hsdRMA– mcrBC) φ80lacZ ΔM15 ΔlacX74 recA1 endA1 araD139 Δ(ara, 
leu)7697 galU galKλ– rpsL nupG
16
16
16
T. Sawai, Chiba
University
Invitrogen
aK. pneumoniae MRY05-304, K. pneumoniae MRY05-305, K. pneumoniae MRY05-306, K. pneumoniae MRY05-307, K. oxytoca MRY05-308 and E. coli 
MRY05-309 correspond to the strains K. pneumoniae 01-140, K. pneumoniae 01-142, K. pneumoniae 03-252, K. pneumoniae 03-518, K. oxytoca 01-141, 
and E. coli 01-139, respectively, which have been described in the previous study (16).
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M7-A818）.  Antimicrobial agents were obtained 
from the following sources: amikacin, Bristol 
Pharmaceuticals K.K., Tokyo, Japan; arbekacin, 
kanamycin, and streptomycin, Meiji Seika Kaisha 
Ltd., Tokyo, Japan; gentamicin and sisomicin, 
Schering-Plough K.K., Osaka, Japan; isepamicin, 
Asahi Kasei Corporation, Tokyo, Japan; tobramycin, 
Shionogi & Co., Ltd., Osaka, Japan; neomycin, 
Nippon Kayaku Co., Ltd., Tokyo, Japan; cefotaxime, 
Aventis Pharma, Ltd., Tokyo, Japan; ceftazidime, 
GlaxoSmithKline K.K., Tokyo, Japan; imipenem, 
Banyu Pharmaceutical Co., Ltd., Tokyo, Japan; and 
ciprofloxacin, Bayer Yakuhin, Ltd., Tokyo Japan.
Detection of genes for 16S rRNA methylsae by 
multiplex PCR analysis
   Primers used for PCR amplification of the 16S 
rRNA methylase genes were followed by Doi 
et al 19）. The supernatant of centrifuged bacterial 
suspension after boiling for 10 minutes was used 
as the DNA template for PCR.  Initial denaturation 
at 94˚C for 2 minutes was followed by 30 cycles 
of amplification with 94˚C for 1 minute, annealing 
at 60˚C for 1 minute, and extension at 72˚C for 1.5 
minutes.  The final extension step was 72˚C for 5 
minutes.  PCR products were analyzed with a 2% 
agarose gel electrophoresis followed by ethidium 
bromide staining.
Detection of genes for β-lactamase by PCR analysis
   PCR primers for detection of blaTEM, blaSHV, 
blaCTX-M-1-type, blaCTX-M-2-type, and blaCTX-M-9-type 
genes and amplification conditions were designed in 
accordance with the instructions of Nagano et al.20）. 
The DNA template prepared for PCR analysis was 
also used in the multiplex PCR to detect 16S rRNA 
methylase genes.  PCR products were analyzed 
with a 2% agarose gel electrophoresis followed by 
ethidium bromide staining, and all PCR amplicons 
derived from CTX-M-type β-lactamase genes were 
subjected to direct sequencing analyses.  DNA 
sequences were determined on both strands using 
BigDye Terminator Cycle Sequencing Ready 
Reaction kits and an ABI 3100 DNA sequence 
analyzer (Applied Biosystems, Foster City, Calif.). 
The nucleotide sequence was analyzed by the 
BLAST homology search system [http://blast.ncbi.
nlm.nih.gov/Blast.cgi]. 
Conjugation experiments, preparation of plasmids, 
and replicon typing by PCR
   Con juga l  t r ans fe r  o f  p lasmid  f rom s ix 
aminoglycoside-resistant strains to a recipient 
E. coli CSH-2 (Table 1) was performed by broth 
mating method.  Transconjugants were selected 
on LB agar plates containing arbekacin (25μg/
ml), rifampin (100μg/ml) and nalidixic acid (50 
μg/ml).  Plasmid DNA preparation was carried 
out by two methods using Qiagen plasmid midi kit 
(Qiagen K.K., Tokyo, Japan) or the method of Kado 
and Liu21）.   Plasmid replicon typing by PCR was 
followed by Carattoli et al. 22）. 
Digestion of plasmid DNA with restriction enzymes 
and Southern hybridization analysis
   Transformation of E. coli DH10B with the 
plasmid DNA prepared from each parental strain 
was performed using standard electroporation 
techniques.  Transformants were selected on LB 
agar plates containing arbekacin (25μg/ml). 
Plasmids were digested with EcoRI (New England 
Biolabs, Beverly, Mass.), and were electrophoresed 
through 1.0% agarose gel and transferred to nylon 
membrane (Bio-Rad Laboratories, Hercules, CA.). 
Hybridization analysis was performed by the PCR 
DIG detection system (Roche Diagnostics, Tokyo, 
Japan) using digoxigenin-labeled rmtB probes.
PFGE analysis
   Genomic DNA preparations from four K. 
pneumoniae strains MRY05-304, MRY05-305, 
MRY05-306, and MRY05-307, were digested 
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with XbaI (New England Biolabs).  PFGE was 
performed with the CHEF-Mapper system (BioRad 
Laboratories) at a constant voltage of 6 V/cm with 
12- to 40-seconds pulses for 24 hour.  Banding 
patterns of four strains were compared and 
interpreted by the criteria proposed by Tenover 
et al 23）.  The similarity of fingerprinting pattern 
was calculated by the unweight pair group method 
using arithmetic averages by Bio Image Advances 
Quantifier Version 4.1.0.0. (R. M. Luton, Inc. 
Table 2.  Results of antimicrobial susceptibility test
Species and strain
MIC (μg/ml)
KAN TOB AMK ABK GEN SISO ISP STR NEO CAZ CTX IPM CIP
K. pneumoniae MRY05-304 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 256 4 4 >64 ≤ 0.5 ≤ 0.5
K. pneumoniae MRY05-305 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 256 1 2 >64 ≤ 0.5 ≤ 0.5
K. pneumoniae MRY05-306 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 512 4 16 >64 ≤ 0.5 ≤ 0.5
K. pneumoniae MRY05-307 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 256 4 4 >64 ≤ 0.5 ≤ 0.5
K. oxytoca MRY05-308 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 256 4 4 >64 ≤ 0.5 ≤ 0.5
E. coli MRY05-309 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 >1,024 256 4 8 >64 ≤ 0.5 ≤ 0.5
Abbreviations: KAN, kanamycin; TOB, tobramycin; AMK, amikacin; ABK, arbekacin; GEN, gentamicin; SISO, sisomicin; ISP, isepamicin; 
STR, streptomycin; NEO, neomycin; CAZ, ceftazidime; CTX, cefotaxime; IPM, imipenem; CIP, ciproﬂoxacin.
Fig. 1A.　EcoRI restriction fragment patterns of rmtB-carrying plasmids.  M, low range PFG marker (New England Biolabs); 
lanes 1 to 6, transconjugants of E. coli CSH2 that harbor rmtB plasmid isolated from E. coli MRY05-309, K. pneumoniae 
MRY05-304, K. oxytoca MRY05-308, K. pneumoniae MRY05-305, K. pneumoniae MRY05-306, and K. pneumoniae MRY05-
307. 
Fig. 1B.　Southern hybridization by rmtB probe.  The rmtB probe was hybridized to the 13.5-kbp EcoRI restriction fragment 
(arrow) of Fig 2A. 
(A) (B)
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Jackson, Mich.). 
RESULTS
Susceptibilities to antimicrobial agents
   The MICs of aminoglycosides for all six strains 
tested were higher than 1,024μg/ml, while those 
of streptomycin and neomycin ranged from 256 to 
512μg/ml and from 1 to 4μg/ml, respectively. 
MICs of cefotaxime for all six strains were higher 
than 64μg/ml, but those of ceftazidime ranged from 
2 to 16μg/ml.  All six strains were susceptible to 
imipenem (MIC, ≤ 0.5μg/ml) (Table 2). 
Multiplex PCR amplification of 16S rRNA methylase 
genes
   A DNA amplicon approximately 200 bp in size 
was generally observed among all six strains by 
the multiplex PCR for identification of 16S rRNA 
methylase genes, and this finding suggested the 
presence of rmtB among these strains.  All E. coli 
DH10B or E. coli CSH2 transformants showed the 
same results by the same multiplex PCR analysis, 
and this finding suggested that the rmtB would be 
mediated by plasmids.
Typing of β-lactamase gene by sequence analysis
   All six parental strains and transformants were 
positive for blaCTX-M-9-type and blaTEM by PCR. 
Moreover, sequence analysis of each blaCTX-M-9-type 
PCR product revealed that these strains harbored 
blaCTX-M-14 instead of blaCTX-M-9; and blaCTX-M-14 and 
blaCTX-M-9 are indistinguishable by the PCR primers 
and condition employed in this study.
Conjugation experiments and restriction profiles of 
plasmids
   All six plasmids carrying both rmtB and blaCTX-M-14 
were successfully transferred to E. coli CSH2 from 
parent strains by conjugation at a frequency of 10-6 
to 10-7 cells per recipient cell.  The results of the 
plasmid replicon typing show all six plasmids are 
classified as IncA/C.  The restriction patterns of 
plasmids with EcoRI are shown in Fig. 1A.  One- 
to four-band differences were observed among six 
plasmids, although they were prepared from three 
different bacterial species including K. pneumoniae, 
E. coli and K. oxytoca.  More precisely, the plasmids 
prepared from four K. pneumoniae strains gave two 
slightly different restriction patterns, i.e., at most 
Fig. 2.　PFGE fingerprinting patterns of XbaI-digested total 
DNA preparations from 4 K. pneumoniae isolates.  M, lambda 
ladder PFG marker (New England Biolabs) as a molecular 
size marker. Lanes 1 to 4, K. pneumoniae MRY05-304, K. 
pneumoniae MRY05-305, K. pneumoniae MRY05-306, and K. 
pneumoniae MRY05-307. 
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two-band disparities.  Although 4 different profiles 
were observed in the restriction patterns among 
the six plasmids, the rmtB probes hybridized to the 
same 13.5-kbp EcoRI restriction fragment in each 
plasmid by Southern hybridization analysis (Fig. 
1B).
RFLP of total DNA preparations from four K. 
pneumoniae strains
   By PFGE analysis, the fingerprinting profiles of 
4 K. pneumoniae strains were classified into two 
patterns, A and B (Fig. 2).  The similarity between 
the two patterns, A and B, was calculated to be 
60%.  K. pneumoniae MRY05-304 and MRY05-305 
demonstrated pattern A, and strains MRY05-306 
and MRY05-307 showed pattern B.  The banding 
patterns of strains MRY05-304 and MRY05-305 
showed two-band difference.  On the other hand, 
those of strains MRY05-306 and MRY05-307 
demonstrated a three-band difference by PFGE 
analysis, and the former strain was isolated six 
months earlier than the latter strain in the same 
hospital. 
DISCUSSION
   In the present study, a probable patient to patient 
nosocomial transmission of RmtB and CTX-M-14 
co-producing strains and horizontal transmission 
of rmtB and blaCTX-M-14 harboring IncA/C type 
plasmids in Japanese hospital during 2001 and 
2003 was recognized by PFGE typing and plasmid 
analysis.  Although three different bacterial species 
were found to harbor the rmtB, restriction patterns 
of six plasmids prepared from six strains were 
considerably similar, and rmtB probes hybridized 
to the same 13.5-kbp EcoRI restriction fragments. 
These observations imply that the rmtB-carrying 
plasmids originated from a progenitor plasmid 
which also encoded blaCTX-M-14.  rmtB is also 
associated with other resistance genes such as 
plasmid-mediated fluoroquinolone-resistant gene, 
qepA24）, but we could not find qepA by PCR25） 
(data not shown).   Given the fact that the strains 
isolated in Taiwan26，27） and Korea28） also harbor 
both rmtB and blaCTX-M-14, the plasmids carrying 
both rmtB and blaCTX-M-14 would somewhere have 
emerged before 2001 and then been disseminated 
to different geographical areas, very possibly Asian 
countries.  The plasmids would then have further 
been transferred horizontally among various gram-
negative bacilli, causing nosocomial infections in 
separate medical facilities in Asian countries.  These 
findings may predict further global transmission of 
RmtB-producing gram-negative nosocomial bacilli 
which also produce CTX-M-type enzymes. 
   The size of plasmids carrying rmtB and blaCTX-M-14 
was estimated to be more than 100 kbp.  These 
plasmids were classified as IncA/C by PCR 
typing.  IncA/C palsmids identified in various 
Enterobacteriaceae28，29） and other gram-negative 
bacteria30，31） were related to multidrug resistance. 
In Korea, K. pneumonia- and E. coli- harboring 
IncA/C plasmid carrying rmtB and blaCTX-M-14 were 
isolated between 1995 and 200528）.  In our study, 
three different bacterial species harboring rmtB and 
blaCTX-M-14 were found in the same hospital in Japan: 
four K. pneumonia, one K. oxytoca, and one E. coli. 
   Further, plasmid-mediated dissemination of rmtB 
accompanied by widely distributing blaCTX-M-14 
among pathogenic gram-negative bacilli may indeed 
become a grave clinical problem in the near future, 
because aminoglycosides tend to be prescribed 
together with other classes of antimicrobial agents 
including broad-spectrum β-lactams.
   PFGE analysis of four K. pneumoniae strains 
suggested that these four strains independently 
isolated from four patients were separated into two 
different clusters (Fig. 2).  The similarity of the 
two clusters was calculated to be about 60%.  This 
suggested that two different genetic lineages of 
K. pneumoniae strains with a very similar IncA/C 
plasmid had been spread nosocomially in a hospital, 
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and then separately transmitted from patient to 
patient.  As shown in Figure 2, pattern A and pattern 
B had two and three difference of banding pattern 
which demonstrated these two groups were clonal 
strains, respectively23）.  Pattern B demonstrated a 
three-band difference and the former strain was 
isolated six months earlier than the latter one.  This 
finding implied that some rearrangements may well 
have occurred in the plasmid or chromosome of 
these two strains over a period of six months.
   In conclusion, we found a probable nosocomial 
transmission of rmtB-harboring gram-negative 
bac ter ia l  spec ies  be longing  to  the  fami ly 
Enterobacteriaceae.  Indeed, isolation of 16S rRNA 
methylase-producing gram-negative bacteria among 
clinical strains is still very rare at present17）, but the 
possible risk of further plasmid-mediated horizontal 
transfer of 16S rRNA methylase genes into strains 
possessing resistance to both fluoroquinolones and 
broad-spectrum β-lactams, including oxyimino-
cephalosporins, cephamycins and carbapenems, 
should be carefully monitored to prevent future 
global proliferation of gram-negative pathogenic 
bacteria that have acquired a very wide range of 
antimicrobial resistance.
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